Trumenba
Drug timelines are a Plus or Pro feature.
8 regulatory and trial events tracked for Trumenba, covering 2014-11-26 to 2025-12-17. Get the full timeline:
Most recent: EMA Authorised: Trumenba (Neisseria meningitidis serogroup B fHbp (recombinant lipidated fHbp (factor H binding protein)) subfamily A; Neisseria meningitidis serogroup B fHbp (recombinant lipidated fHbp (factor H binding protein)) subfamily B) — Pfizer Europe MA EEIG